Latrepirdine

• CAT Number: A001142
• CAS Number: 97657-92-6
• Molecular Formula: C21H25N3 • 2HCl
• Molecular Weight: 392.41
• Purity: ≥95%
• Target: Immunology/Inflammation
• Solubility: Soluble in DMSO > 10 mM
• Storage: 3 years -20C powder
• IUPAC Name: 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole
• InChI: InChI=1S/C21H25N3/c1-15-4-7-20-18(12-15)19-14-23(3)10-9-21(19)24(20)11-8-17-6-5-16(2)22-13-17/h4-7,12-13H,8-11,14H2,1-3H3
• InChIKey: JNODQFNWMXFMEV-UHFFFAOYSA-N
• SMILES: CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C

Latrepirdine(CAT: A001142) is a small-molecule compound with neuroprotective and neuromodulatory properties, originally developed as an antihistamine. It has gained interest in neuroscience research for its potential role in treating neurodegenerative diseases such as Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease. Latrepirdine is believed to enhance mitochondrial function, regulate calcium homeostasis, and modulate neurotransmitter systems, contributing to its neuroprotective effects. With its diverse pharmacological activities, Latrepirdine serves as a valuable tool in preclinical studies aimed at understanding neurodegeneration mechanisms and exploring innovative therapeutic approaches for age-related and progressive neurological disorders.